Tougher Times Ahead as Labs React to Fee Cuts

By Joseph Burns | From the Volume XXIV No. 16 – November 20, 2017 Issue

CEO SUMMARY: Just as Nero is reputed to have fiddled while Rome burned, officials at CMS seem to be doing their own fiddling as their planned deep price cuts to Medicare Part B lab tests could begin driving lab companies out of business. In recent weeks, the owners of two lab companies de…

Read More

---

New company ready to heat up slow digital pathology market

By Mary Van Doren | From the Volume XXII No. 11 – August 3, 2015 Issue

IN THE 2000S, DIGITAL PATHOLOGY WAS THE HOT NEW TECHNOLOGY that held great potential to transform anatomic pathology in myriad ways, not the least of which was an essential tool to streamline pathologist workflow while suppor…

Read More

---

New Company Ready to Heat Up Slow Digital Pathology Market

By Robert Michel | From the Volume XXII No. 11 – August 3, 2015 Issue

CEO SUMMARY: There’s a new competitor in the digital pathology marketplace with ambitious plans to deliver a fully-integrated pathologist workflow solution. Inspirata, Inc., of Tampa, Florida, made its debut in March at an international pathology conference. In this exclusive i…

Read More

---

LabCorp, Quest Diagnostics Both Say 2014 Revenue Was Up

By Robert Michel | From the Volume XXII No. 5 – March 30, 2015 Issue

BOTH OF THE NATION’S LARGEST clinical laboratory companies reported increased specimen volume as a result of the Accountable Care Act (ACA), as noted in their respective fourth quarter and full-year earnings reports. First to issue its earning statement was Quest Diagnostics Incorporated. On…

Read More

---

Anatomic Pathology Business Faces Uncertain Future

By Robert Michel | From the Volume XXI No. 4 – March 17, 2014 Issue

CEO SUMMARY: There’s a day of reckoning on the way for the traditional business model of the private pathology group practice. At most risk are smaller pathology groups that typically have five or fewer pathologists. Blame it on the reduced prices that Medicare and private insurers are …

Read More

---

Urologists Weigh in on Prostate Biopsy Testing

By Joseph Burns | From the Volume XX No. 3 – March 4, 2013 Issue

CEO SUMMARY: Based on an impressive number of 4,230,129 vials collected from 437,937 biopsies, the new study is expected to add fuel to the fire of the ongoing debate about the appropriate number of prostate biopsies physicians should collect and refer to pathology labs for cancer testing…

Read More

---

Labs Have Questions about Prostate Biopsy Policy

By Joseph Burns | From the Volume XIX No. 13 – September 17, 2012 Issue

CEO SUMMARY: How will pathology laboratories respond to the publication of revised policies in how laboratories should file Medicare Part B claims for prostate biopsies? Not only will there be a sharp drop in the reimbursement paid for a 12-core prostate biopsy, but labs may be at increas…

Read More

---

AP Labs in Doc’s Clinics Now an Established Fact

By Robert Michel | From the Volume XVIII No. 12 – September 6, 2011 Issue

CEO SUMMARY: It started about eight years ago and shows no signs of slowing down. Specialist physicians, particularly urologists and gastroenterologists, have learned about the benefits of operating their own in-clinic anatomic pathology laboratories. One-by-one, these specialty …

Read More

---

Bostwick Laboratories Puts Facilities on Market

By Robert Michel | From the Volume XXVIII No. 11 – August 15, 2011 Issue

CEO SUMMARY: Events are unfolding rapidly at Bostwick Laboratories, Inc., of Glen Allen, Virginia. In recent months, the company has listed its facilities in Arizona, Tennessee, New York, and Virginia for sale or lease. In July, it agreed to pay a civil fine of $129,000 to settle…

Read More

---

Smaller Pathology Groups Explore Consolidation

By Robert Michel | From the Volume XVIII No. 5 – April 11, 2011 Issue

CEO SUMMARY: In eastern Washington State, InCyte Pathology is developing a strategy that may well be repeated many times over in the coming years. As older pathologists who run smaller groups look to retire, they will consider selling their group practices to larger entities inte…

Read More

---